New Product Development Benchmarking Reports

How do leading bio-pharmaceutical companies effectively shorten the new product development cycle? Specifically, how do these companies drive early-stage product commercialization through new product planning (NPP)? What is the role played by additional departments, such as medical affairs, in expediting new product development? What ore the pros and cons for different new product planning department structures? What are the most effective/valuable NPP activities?

These are some of the critical product development questions facing bio-pharmaceutical companies today. Best Practices, LLC’s new product development reports provide benchmarks and best practices that enable organizations to select the appropriate structure, review operations and re-examine resources to drive new product planning and development success. Designed to build organizational value and effectiveness, our product development reports also help bio-pharmaceutical organizations optimize product portfolios and spot emerging future trends facing the NPP function.